IMU

5.56%

5.7¢ imugene limited

Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-97

First 97 Last

Share
Profile

Follow
DDD24

499 Posts.

110

08/04/24

19:40

Post #: 73246297
Share

Originally posted by Outlander2: ↑

Hi Odds & Evens, @Odds&Evens

I hope you are traveling well in that beautiful city of yours.

I agree with you completely ... “a treatment option for advanced cancer” is a very clear statement. It’s not ‘a possible’ or ‘a potential’, it is a ‘treatment option’ ... no ‘ifs’, no ‘buts’.

Reading your last paragraph, I think you are suggesting that we may see a ‘joint statement’ from the FDA and IMU? If this is not what you meant then I have misunderstood and would apologise. Is this what you mean?

If this is what you did intend, then I would be surprised to see any ‘joint statement’. This is not how I would expect the FDA to make an announcement.

Now, what could happen, if Yuman, or whoever, were to announce a positive and stunning update, we could see IMU quickly release correspondence they had received from the FDA. This could happen if they had already been in consultation around a new expansion trial, or if something amazing was occurring around the higher dosing in the MAST trial. And of course, this would land without warning.

Having said that, I would not expect the FDA to comment on the availability of the treatment before a registrational trial was well underway. I could be wrong ... because IMU is operating at the very pointy end of the ‘cutting edge’ of science, and we are talking about a cure for solid cancers. This is obviously uncharted waters.

Hi Learner, @MrLearner

I hope you are still traveling well also, I know you have had your challenges.

I’m sure Dave, Jov, myself and a few others will certainly look to unpack the implications of whatever is announced ... to the best of our abilities. As I have mentioned before, we do have at least two oncologists ‘following’ these threads. They rarely post, but when they do, they show a very clear understanding of the processes.

Anyway, I’m just hoping we have something to unpack soon, and I hope its stunning. In my opinion, it really could be mind-blowing.

All opinion only, of course.

Expand

Time to be real, a company can spin words to not cause concern amongst shareholders.

Wheres the data…that’s all that counts not words spun from the marketing dept.

IMU Price at posting: 10.5¢ Sentiment: Hold Disclosure: Held
6 Upvote

2 Great analysis

Reply

Top Stories

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

RCE

Recce's R327 found effective against E.coli during clinical trial

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

There are more pages in this discussion • 208 more messages in this thread...

First 97 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.7¢		Change 0.003(5.56%)		Mkt cap ! $417.2M

Open	High	Low	Value	Volume
5.5¢	5.8¢	5.2¢	$2.499M	45.00M

Buyers (Bids)

No.	Vol.	Price($)
2	1921794	5.6¢

Sellers (Offers)

Price($)	Vol.	No.
5.7¢	1368288	7

View Market Depth

No.	Vol.	Price($)
5	286362	0.055
9	2036888	0.054
16	2736044	0.053
20	1943436	0.052
23	3206056	0.051

Price($)	Vol.	No.
0.057	378902	2
0.058	1552127	7
0.059	837099	8
0.060	2176188	16
0.061	1163926	6

Last trade - 16.10pm 28/06/2024 (20 minute delay)

IMU (ASX) Chart

Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-97

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Recce's R327 found effective against E.coli during clinical trial

Ava Risk Group expands US presence with A$0.7M Substation Deal

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-97

Top Stories

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Recce's R327 found effective against E.coli during clinical trial

Ava Risk Group expands US presence with A$0.7M Substation Deal

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News